Vivos Therapeutics (VVOS) Non-cash Items (2019 - 2026)

Vivos Therapeutics (VVOS) has 8 years of Non-cash Items data on file, last reported at $174000.0 in Q1 2026.

• Non-cash Items for Q1 2026 came in at $174000.0, up 15.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $174000.0 (up 15.23% YoY), and the FY2024 annual result was $121000.0, up 35.96% from the prior year.
• Non-cash Items improved to $174000.0 in Q1 2026 per VVOS's latest filing, from $151000.0 in the prior quarter.
• Over five years, Non-cash Items peaked at $2.2 million in Q3 2022 and troughed at $89000.0 in Q4 2023.
• A 5-year average of $957818.2 and a median of $174000.0 in 2026 frame the typical range for Non-cash Items.
• On a YoY basis, Non-cash Items climbed as much as 84.43% in 2022 and fell as far as 95.26% in 2022.
• A 5-year view of Non-cash Items shows it stood at $90000.0 in 2022, then declined by 1.11% to $89000.0 in 2023, then surged by 35.96% to $121000.0 in 2024, then increased by 24.79% to $151000.0 in 2025, then rose by 15.23% to $174000.0 in 2026.
• Business Quant data shows VVOS's Non-cash Items at $174000.0 in Q1 2026, $151000.0 in Q1 2025, and $121000.0 in Q4 2024.